Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Maybe this time?

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Sep 13, 2021 12:19am

136 Views

Post# 33847262

RE:Maybe this time?

I hope I am wrong but I suspect we will need to wait for the cancer data to get the big catalyst we are looking for. With less than ideal analyst coverage, even good news on NASH is not likely to trigger a positive re-rating of the stock tomorrow.

longterm56 wrote: Hello all -

We've seen many "catalysts" come and go with no SP action. We all know that THTX's valuation is woefully anemic, and one of these days it will respond appropriately. Here is hoping that "one of these days" is tomorrow!

-LT